The Net Margin of Fusion Antibodies PLC (FAB.L) is -195.95%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | -195.95% |
| 2023-03-31 | -89.49% |
| 2022-03-31 | -25.01% |
| 2021-03-31 | -69.60% |
| 2020-03-31 | -17.89% |
| 2019-03-31 | -57.95% |
| 2018-03-31 | -26.01% |
| 2017-03-31 | 6.27% |
| 2016-03-31 | 77.91% |
| 2015-03-31 | -9.36% |